CONFRONTING PICTURE OF GROWING WOMEN’S HEALTH CRISIS IN UTERINE CANCERS. ANZGOG State of the Nation report highlights inequities in uterine cancer outcomes across Australia
With
Associate Professor Yoland Antill, Director and Deputy Chair, Australia New Zealand Gynaecological Oncology Group (ANZGOG)
SEGMENT
Filmed in Melbourne | December 2025
Uterine cancers have become Australia’s fastest-growing women’s cancer, with incidence doubling over the past 25 years and projected to continue to surge. Without immediate action, more than 44,000 women are expected to be diagnosed by 2035, and 8,900 will lose their lives to the disease.
Released November 2025, Australia’s first State of the Nation: Uterine Cancers in Australia 2025 report by the Australia New Zealand Gynaecological Oncology Group (ANZGOG), reveals a confronting picture of a growing women’s health crisis that has gone largely unseen and one that now requires immediate, coordinated national action.
Once considered a cancer that primarily affected older women, the report highlights an alarming new trend: incidence is now rising fastest among women aged 25 to 44, with cases in this age group expected to increase by around 60 per cent alone, over the next decade.
Despite its growing impact, uterine cancer remains largely invisible in Australia’s cancer conversation. The limited research available notes, 94 per cent of women are unaware of what uterine or endometrial cancers are yet increased awareness of the disease and risk factors could prevent up to 60 per cent of future diagnoses. Research investment for uterine cancers lags far behind other cancers.
In addition, support and psychosocial care for women living with uterine cancers are inconsistent, and currently there is no dedicated national advocacy organisation. Many women face pain, fatigue, anxiety and long-term side effects alone.
State of the Nation report sets out a national plan to reverse the rise in uterine cancers and transform outcomes for Australian women
The report identifies five urgent priorities: halve incidence, eliminate inequities, ensure access to precision care, support every woman to live well, and invest in research and data. Achieving these goals will require united action from government, researchers, clinicians, industry and the community to deliver the innovation, equity and support Australian women deserve.
Source: Adapted from ANZGOG media release November 2025
Report: ANZGOG State of the Nation Report into Uterine Cancers can be read here https://www.anzgog.org.au/sotn-uterine-cancer, prepared by Insight Economics
-
Keeping elderly out of hospital
Pioneer in health care, Geriatrician Professor Susan Kurrle, Curran Professor in Health Care of Older People at the Faculty of Medicine and Health, University of Sydney AO spoke after receiving the Australian Healthcare and Hospitals Association 2022 Sidney Sax medal award.
The Sidney Sax medal is awarded for outstanding contributions to the development and improvement of Australia’s healthcare system.
-
Health-Tech Connections
Challenges in health care delivery have compounded, with clinical staff being exposed to the Omicron COVID variant. Reduced staffing has brought on its challenges to most already-strained state health care systems and the people working in them.
However, over the past 2 years of the pandemic, technology has played an increasing role on the front end for patients and consumers at home and clinicians in the medical setting. Much more is planned in technology that will deliver efficiency, reduce risk and make available new models of care. This has the potential to touch the working lives of all stakeholders and
recipients of care. -
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
